ACN Accenture plc Insider Trading

Co-CEO Asia Pacific Egawa Atsushi sold 4,872 shares of ACN across 4 transactions for $863,044.24, reducing holdings by 27.6%.

Egawa Atsushi, Co-CEO Asia Pacific at Accenture, executed 4 separate sales totaling 4,872 shares for $863,044.24 at prices ranging from $174.53 to $178.58 per share. The sales reduced his post-transaction holdings to 12,802 shares from 17,674 shares, representing a net reduction of 27.6%. Notably, the stock has declined 9.9% over the past 30 days and 32.2% over the past 90 days, trading 44.7% below its 52-week high of $323.21, despite the company's solid fundamentals (P/E of 14.88, $18.0B quarterly revenue, 7.4% annual growth). The timing of this divestment relative to recent price weakness and the magnitude of the position reduction merit observation, though the absence of prior transaction context limits broader pattern assessment.

CEO Sweet Julie Spellman sold 6,057 shares for $1,461,101.58 at ACN; stock down -14.2% in 30 days

CEO Sweet Julie Spellman executed 6 separate sales totaling 6,057 shares for $1,461,101.58 on 2026-02-10, reducing her holdings by 28.4% to 15,255 shares post-transaction. The sales occurred across a narrow price range ($236.11–$243.15), with a blended average of $241.23, while the current price sits at $240.86—suggesting these were disciplined executions near prevailing levels. The timing context is material: ACN has fallen 14.2% over the prior 30 days and 39.5% from its 52-week high of $398.25, despite solid fundamentals (revenue $18.7B, net income $2.2B, P/E 20.16). Spellman's same-ticker history shows 5 consecutive sells on 2026-02-03 (outcomes not yet measurable), indicating sustained portfolio reduction activity rather than a one-off event. Her cross-ticker track record across 20 prior sells shows mixed timing (36.36% well-timed rate), so this filing should be monitored against post-sale price action to assess whether the reduction signals forward-looking caution in a declining equity or simply portfolio management.

CEO Sweet Julie Spellman sold 5,500 shares of ACN for $1,333,120.52 in 9 separate transactions on 2026-02-03.

Sweet Julie Spellman, Chair and CEO, executed 9 separate sales totaling 5,500 shares for $1,333,120.52 on 2026-02-03, reducing her holdings by -20.6% from 26,650 to 21,150 shares. The blended average price of $242.39 is $1.26 above the current price of $241.65, placing the transaction near recent levels. Her same-ticker trade history shows a marked contrast: 4 of 5 prior sells at ACN registered negative 90-day returns, indicating well-timed exits before subsequent declines. At the current price of $241.65, the stock trades -39.3% from its 52-week high of $398.25 and -8.5% over the past 30 days. The CEO's cross-ticker track record shows 20 prior sells with a 45.00% well-timed rate, while her ACN-specific pattern of 4 of 5 prior sells followed by 90-day declines suggests deliberate timing discipline at this particular ticker.

CAO Melissa A Burgum sold 3,588 shares for $1,008,280.65; prior ACN sells 100% well-timed at 90 days

Melissa A Burgum, Chief Accounting Officer at Accenture plc, executed 5 separate sales on 2026-01-26 totaling 3,588 shares for $1,008,280.65, reducing her holdings by 30.5% from 11,767 to 8,179 shares. Her prior 4 trades at ACN all showed negative 90-day returns (ranging from -16.6% to -17.3%), establishing a 100% well-timed sell pattern at this ticker. The stock is currently trading at $275.80, down 30.8% from its 52-week high of $398.25, though up 1.7% over 30 days. The timing pattern across her ACN sales is notable: every prior occasion where Burgum sold has been followed by subsequent stock declines at the 90-day horizon, suggesting her sale decisions have historically preceded downward price movement.

CEO John F Walsh sells 3,986 shares of ACN for $1.1M; strong 90-day sell timing pattern across 5 prior trades.

Walsh executed 5 separate sales totaling 3,986 shares for $1,101,644.48 on 2026-01-27, reducing his holdings by 12.8% to 27,221 shares. His same-ticker trade history at ACN reveals a noteworthy pattern: all 5 prior sales were well-timed at the 90-day mark, each followed by negative 90-day returns ranging from -19.5% to -26.6%. This current transaction follows that established pattern of disciplined exit timing. The blended sale price of $276.38 was executed near current levels ($275.80), positioning the sale relative to a 52-week range of $232.56–$398.25 where the stock is currently 30.8% below its high. Fundamentally, ACN remains substantial (revenue $18.7B, market cap $175.7B), and the cross-ticker track record shows 75.00% well-timed sales historically, though ACN-specific outcomes dominate the timing signal here.

Chief Strategy Officer Manish Sharma sold 2,731 shares of ACN for $786,870.53; post-transaction holdings 7,057 shares (-27.9%).

Manish Sharma, Chief Strategy & Services Officer, executed 7 separate sales totaling 2,731 shares for $786,870.53 on 2026-01-14, reducing his holdings by 27.9%. His prior trades at ACN show a 4-of-4 well-timed selling pattern at the 90-day mark, suggesting a demonstrated ability to execute sales ahead of declines at this specific ticker. The current transaction occurred at a blended average price of $288.13, near the current price of $287.77, yet the stock remains -27.7% from its 52-week high of $398.25. Recent 30-day and 90-day price performance (+5.8% and +20.7% respectively) provide context for the timing, though the multi-part structure and range of transaction prices ($276.61–$290.21) suggest execution across intraday levels rather than a single market event.

ACN Chair/CEO Julie Spellman sells 5,917 shares for $1,459,276.66 across 4 transactions at $246.62 avg; stock now down 3.9% in 30 days

Julie Spellman, Chair and CEO of Accenture plc, executed 4 separate sales on 2025-11-05 totaling 5,917 shares for $1,459,276.66 at a blended average price of $246.62, reducing her holding by 40.3% from 14,673 to 8,756 shares. The sales occur as ACN trades at $241.34, down 3.9% over the past 30 days and 39.4% below its 52-week high of $398.25, creating a gap between the blended transaction prices ($246.62) and current market levels. Spellman's cross-ticker track record shows prior sells averaged -3.0% returns within 30 days and -5.4% within 90 days, with a 50.00% well-timed rate; her five prior trades at ACN remain unmeasurable in outcome, having all occurred within the past two weeks. This multi-sale pattern on a single date warrants attention to the timing context and company fundamentals, though the outcome cannot yet be assessed against the historical pattern.

CEO Sweet Julie Spellman sells 9,000 ACN shares for $2.3M across 4 transactions on 2025-10-29

Sweet Julie Spellman, Chair and CEO, executed 4 separate sales totaling 9,000 shares for $2,280,586.99 on 2025-10-29 at a blended average price of $253.40, reducing her holdings by 38.3%. The current stock price of $249.25 is 37.4% below the 52-week high of $398.25, reflecting meaningful pullback from peak valuation despite Accenture's solid fundamentals (revenue $17.7B, net income $2.2B, 7.4% annual revenue growth, P/E 18.98). Spellman's cross-ticker track record shows 20 prior sells with a 62.50% well-timed rate at the 90-day mark, though her prior trades at ACN (5 distinct positions) show mixed timing—only 1 of 1 measurable sales was well-timed (the July 2025 sale with -11.1% 90-day return), while 4 more recent sales from October 22 lack measurable outcome windows. The concentration of sales in late October during a period of 30-day weakness (-2.4% over 90 days) warrants attention to whether this reflects a planned divestiture or discretionary timing.

Co-CEO Asia Pacific Sekido Ryoji sold 2,500 shares ($623.7K) at $249.47 avg; all 5 prior ACN sells were well-timed 90d declines.

Sekido Ryoji executed 3 separate sales totaling 2,500 shares for $623,674.58, reducing his ACN holdings by 64.3% from 3,890 to 1,390 shares. His prior trading history at ACN is striking: all 5 previous sells, each from 2025-02-05, registered negative 90-day returns (-13.0% to -13.5%), yielding a 100% well-timed rate at this ticker. Against that backdrop, this latest sale occurs near the 52-week high ($398.25), with the stock currently -37.3% from peak and down -11.8% over the past 90 days, positioning this sale within the context of his demonstrated pattern of selling into strength before subsequent declines. The stock's 30-day gain of +6.1% does not contradict the 90-day downward trend, and fundamentals remain solid (P/E 19.03, +7.4% annual revenue growth, $2.2B net income), yet the insider's persistent execution of well-timed exits at this ticker merits investor attention.

Accenture CEO Julie Spellman sold 9,000 shares for $2.2M; 5 of 5 prior same-ticker sales were well-timed.

Julie Spellman (Chair and CEO) executed 4 separate sales totaling 9,000 shares for $2,246,165.56 at a blended average price of $249.57 on 2025-10-22, reducing her holdings from 32,516 to 23,516 shares (a -27.7% reduction). This sale occurs while ACN trades at $249.81, near its transaction price but -37.3% below its 52-week high of $398.25 and -11.8% below its 90-day price level. Notably, all 5 of Spellman's prior same-ticker sales (on 2025-07-11) were well-timed at the 90-day mark, with negative returns of -15.6% to -16.7% over 90 days, indicating a consistent pattern of selling into declines. The company's fundamentals remain solid (P/E of 19.03, $17.7B quarterly revenue, +7.4% annual growth), but the insider's historical accuracy at this ticker and the current stock price positioning relative to the 52-week range merit investor attention.